Before the SEC brought civil insider-trading charges against the Deutsche Bank bond salesman who allegedly tipped off a hedge fund portfolio manager, Deutsche Bank conducted its own investigation of contacts between the two men, in which Khuzami himself questioned the bank's bond salesman. After the internal investigation, Deutsche Bank took no action against its salesman--meaning that the SEC lawyers who filed suit disagreed with the judgment of the man who's now their boss.

An appellate panel agreed that Frederick Schiff is not criminally liable for alleged omissions in SEC filings, nor for alleged misstatements by a colleague in phone calls with analysts.

Following Google's $5 million patent trial loss last month to Bedrock Computer Technology, it took a jury in the same Tyler, Texas courtroom just 40 minutes to reach a verdict of non-infringement on Tuesday in Bedrock's case against Yahoo over the same patent.

Despite a formidable defense lineup and the U.S. Supreme Court's Wal-Mart v. Dukes ruling, Phillip Morris failed on Wednesday to knock out a class of Massachusetts smokers who want the tobacco giant to pay for their lung cancer screening.

A Philadelphia judge has refused to dismiss a class action suit accusing Bank of America of engaging in a scheme to use mortgage insurance premiums to fund illegal kickbacks. In his Thursday ruling, the judge directed the parties to develop a record on the issue of whether the statute of limitations should be equitably tolled based on the plaintiffs' claims.

In the graveyard of pleadings in pharmaceutical product liability cases, it's pretty rare to find a persuasive argument casting a drug company defendant as the victim. But Teva and Baxter attempt the feat, in a 105-page tale of woe at the hands of a Las Vegas trial judge.

Billions of dollars of revenue were at stake in challenges to an antipsychotic co-marketed by Bristol-Myers and a Lilly lung cancer treatment. But courts in Delaware and New Jersey upheld the brands' patents.